Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
Renato Tambucci,1 Claudia Basti,1 Maria Maresca,1 Giangennaro Coppola,2 Alberto Verrotti11Department of Pediatrics, University of L’Aquila, L’Aquila, Italy; 2Child and Adolescent Neuropsychiatry Unit, University of Salerno, Salerno, ItalyAbstract: Eslicarbazepine acetate...
Guardado en:
Autores principales: | Tambucci R, Basti C, Maresca M, Coppola G, Verrotti A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15e3e34c47e24dbfaef04045081c49bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
por: Sunkaraneni S, et al.
Publicado: (2017) -
EFFICACY OF BRIVARACETAM IN PEDIATRIC EPILEPSY: AN UP-TO-DATE
por: Antonio Nicotera
Publicado: (2021) -
Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel
por: Edward Faught, et al.
Publicado: (2021) -
An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients
por: Dozières-Puyravel B, et al.
Publicado: (2019) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa AM
Publicado: (2019)